Dr. Jeffrey Gladden says a $30 million investment could fund two to three parallel aging intervention trials at once, compared to the $6 million single studies happening now. He argues current funding is too concentrated on a few projects, leaving huge gaps in what researchers could test.
To be perfectly honest, the main reason why we have made the choices we have is because we're focused on getting as much knowledge as possible per dollar and per unit time, of course. Mm-hmm. So this study, the last study cost about $3.5 million. This study, we've got a few cost savings, but it's twice the size. So it's going to be probably $6 million. If somebody dropped $30 million on me today, then I would totally do 2 8 intervention studies in parallel, maybe 3, because we can, because there's enough options out there. And for that matter, because there are questions about dosage, we would love to be able to— right. More. Yeah. The horrifying thing is that nobody's doing it. There's billions of dollars floating around being used for just a small proportion of the things that are interesting. So much knowledge could be gained by doing, by doing this kind of work.
